VENUS REMEDIES LTD. - 526953 - Board Meeting Outcome for Outcome Of Board Meeting
As per Attachment.27-05-2022
27-05-2022
VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith newspaper publication of notice for issue of duplicate shares in lieu of loss of shares.27-05-2022
VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Meeting Of Board Of Directors Is Scheduled To Be Held On 27Th May 2022.
VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 27th May 2022 inter alia: 1. To consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March 2022. 2. Any other business with the permission of Chair.16-05-2022
VENUS REMEDIES LTD. - 526953 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report of the Company for the year ended on 31st March, 2022 as required under Regulation 24(A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201512-05-2022
Venus Remedies dispatches first batch of essential medicines to Ukraine
The company has launched a social media campaign to motivate people in India and abroad to make voluntary contributions for the cause05-05-2022
VENUS REMEDIES LTD. - 526953 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation39(3) of the SEBI (LODR), notice is hereby given that the share certificate has been reported to be lost/ misplaced and the registered holders/claimant therefore have requested the Company for issuance of Duplicate Share Certificate(s) in lieu of lost share certificates(s.19-04-2022
VENUS REMEDIES LTD. - 526953 - Compliance Under Regulation 40(10) Of Sebi LODR As On 31.03.2022.
Compliance under Regulation 40(10) of SEBi LODR as on 31.03.2022.14-04-2022
VENUS REMEDIES LTD. - 526953 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 026260 Name of the Signatory :- NEHADesignation :- Company Secretary and Compliance Officer14-04-2022
VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release- Venus Remedies gets CII's Responsible Export Organization Certification13-04-2022